与其他固体瘤相比,在质瘤患者中保持疫苗诱导的免疫力

Alexander Yuile1,2,3,4, Joe Q Wei2,5, Kelly J McKelvey1,6

  • 1Bill Walsh Translational Cancer Research Laboratory, Kolling Institute, Royal North Shore Hospital, Northern Sydney Local Health District, St. Leonards, NSW, 2065, Australia.

Journal of neuro-oncology
|October 15, 2025
PubMed
概括

质瘤患者对DNA和mRNA疫苗表现出有希望的免疫反应,这表明未来质瘤疫苗治疗的可行性. 这项研究通过评估对COVID-19疫苗的免疫反应来模拟潜在的癌症治疗方法.